Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Daiichi Sankyo Begins PII Study of ADC Patritumab for HER3-Positive Colorectal Cancer
Daiichi Sankyo has kickstarted a global PII clinical study of its HER3 directed DXd antibody drug conjugate (ADC) patritumab deruxtecan (U3-1402) in previously treated patients with HER3 expressing advanced/metastatic colorectal cancer. The PII study will assess the safety and efficacy…
To read the full story
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





